Viewing Study NCT01263418

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 4:57 AM
Ignite Modification Date: 2025-12-26 @ 3:56 AM
Study NCT ID: NCT01263418
Status: WITHDRAWN
Last Update Posted: 2015-10-12
First Post: 2010-12-16
Is NOT Gene Therapy: False
Has Adverse Events: False
Brief Title: Ofatumumab In Older Patients With Untreated Low Or Intermediate Risk Indolent B-Cell Lymphomas
Sponsor: UNC Lineberger Comprehensive Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lymphoma, Non-Hodgkin View
None Lymphoma, Follicular View
None Lymphoma, B-Cell, Marginal Zone View
None Lymphoma, Low-Grade View
None Lymphoma, Intermediate-Grade View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Follicular Lymphoma View
None Marginal Zone Lymphoma View
None Non-Hodgkins Lymphoma View
None Elderly View
None Newly Diagnosed View
None Lineberger Comprehensive Cancer Center View
None University of North Carolina View
None Ofatumumab View
None Arzerra View
None Phase 2 View
None Geriatric View
None Lymphoma View